|
"yeh kh"的相关文件
显示项目 1-50 / 108 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2023-05-24 |
Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
|
Yoshino, T;Cervantes, A;Bando, H;Martinelli, E;Oki, E;Xu, RH;Mulansari, NA;Govind Babu, K;Lee, MA;Tan, CK;Cornelio, G;Chong, DQ;Chen, LT;Tanasanvimon, S;Prasongsook, N;Yeh, KH;Chua, C;Sacdalan, MD;Sow Jenson, WJ;Kim, ST;Chacko, RT;Syaiful, RA;Zhang, SZ;Curigliano, G;Mishima, S;Nakamura, Y;Ebi, H;Sunakawa, Y;Takahashi, M;Baba, E;Peters, S;Ishioka, C;Pentheroudakis, G |
| 臺大學術典藏 |
2022-05-30T02:36:16Z |
On Privacy Aware Carriers for Value-Possessed e-Invoices Considering Intelligence Mining
|
Cha, SC; Wang, H; Tan, ZY; YUH-JZER JOUNG; Tseng, YC; Yeh, KH |
| 國家衛生研究院 |
2022-02-16 |
Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Lin, CW;Liou, JM;Wu, MS;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2021-09-04 |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study
|
Kang, YK;Morita, S;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Chen, LT;Boku, N |
| 國家衛生研究院 |
2021-03-20 |
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
|
Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Nishiyama, T;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2020-04-06 |
JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
|
Yoshino, T;Pentheroudakis, G;Mishima, S;Overman, MJ;Yeh, KH;Baba, E;Naito, Y;Calvo, F;Saxena, A;Chen, LT;Takeda, M;Cervantes, A;Taniguchi, H;Yoshida, K;Kodera, Y;Kitagawa, Y;Tabernero, J;Burris, H;Douillard, JY |
| 中山醫學大學 |
2020 |
Observational study of dronedarone in Taiwanese patients with atrial fibrillation
|
Lin, JL; Wu, TJ; Chen, CP; Hsu, JC; Ueng, KC; Kuo, JY; Chen, MC; Yeh, KH; Chang, KC; Lu, YY; Shyu, KG; Wen, MS; Chen, SA; Hsieh, MH; Tseng, WK; Feng, AN; Yang, TY; Ko, WC; Cheng, CW; Liu, JC; Lai, WT |
| 國家衛生研究院 |
2019-12-20 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen, LT;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Kang, YK;Boku, N |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-05-13 |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh, T;Kang, YK;Chao, Y;Ryu, MH;Kato, K;Cheol Chung, H;Chen, JS;Muro, K;Ki Kang, W;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Tanimoto, M;Chen, LT;Boku, N |
| 國家衛生研究院 |
2019-04-17 |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Wu, MS;Yeh, KH;Lin, CW;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2018-11-22 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro, K;Van Cutsem, E;Narita, Y;Pentheroudakis, G;Baba, E;Li, J;Ryu, MH;Zamaniah, WIW;Yong, WP;Yeh, KH;Kato, K;Lu, Z;Cho, BC;Nor, IM;Ng, M;Chen, LT;Nakajima, TE;Shitara, K;Kawakami, H;Tsushima, T;Yoshino, T;Lordick, F;Martinelli, E;Smyth, EC;Arnold, D;Minami, H;Tabernero, J;Douillard, JY |
| 國家衛生研究院 |
2018-11-22 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro, K;Lordick, F;Tsushima, T;Pentheroudakis, G;Baba, E;Lu, Z;Cho, BC;Nor, IM;Ng, M;Chen, LT;Kato, K;Li, J;Ryu, MH;Zamaniah, WIW;Yong, WP;Yeh, KH;Nakajima, TE;Shitara, K;Kawakami, H;Narita, Y;Yoshino, T;Van Cutsem, E;Martinelli, E;Smyth, EC;Arnold, D;Minami, H;Tabernero, J;Douillard, JY |
| 國家衛生研究院 |
2018-01 |
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma
|
Javle, M;Lowery, M;Shroff, RT;Weiss, KH;Springfeld, C;Borad, MJ;Ramanathan, RK;Goyal, L;Sadeghi, S;Macarulla, T;El-Khoueiry, A;Kelley, RK;Borbath, I;Choo, SP;Oh, DY;Philip, PA;Chen, LT;Reungwetwattana, T;Van Cutsem, E;Yeh, KH;Ciombor, K;Finn, RS;Patel, A;Sen, S;Porter, D;Isaacs, R;Zhu, AX;Abou-Alfa, GK;Bekaii-Saab, T |
| 國家衛生研究院 |
2017-12 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Kang, YK;Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Chen, LT |
| 國家衛生研究院 |
2017-11-16 |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|
Yoshino, T;Arnold, D;Taniguchi, H;Pentheroudakis, G;Yamazaki, K;Xu, RH;Kim, TW;Ismail, F;Tan, IB;Yeh, KH;Grothey, A;Zhang, S;Ahn, JB;Chong, D;Chen, LT;Kopetz, S;Eguchi-Nakajima, T;Ebi, H;Ohtsu, A;Cervantes, A;Muro, K;Tabernero, J;Minami, H;Ciardiello, F;Douillard, JY |
| 國家衛生研究院 |
2017-10 |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
|
Chen, LT;Oh, DY;Ryu, MH;Yeh, KH;Yeo, W;Carlesi, R;Cheng, R;Kim, J;Orlando, M;Kang, YK |
| 國家衛生研究院 |
2017-10 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Wei, MF;Liou, JM;Wang, HP;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2017-02 |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
Kuo, SH;Tsai, HJ;Lin, CW;Yeh, KH;Lee, HW;Wei, MF;Shun, CT;Wu, MS;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2017-01 |
Expressions of the CagA protein and CagA-signaling molecules predict H. pylori-dependence of early-stage gastric DLBCL
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Shun, CT;Tzeng, YS;Liou, JM;Wu, MS;Hsu, PN;Cheng, AL |
| 國家衛生研究院 |
2016-10 |
CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma
|
Kuo, SH;Tsai, HJ;Yeh, KH;Lin, CW;Zeng, YS;Wu, MS;Hsu, PN;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2016-05 |
Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Tsai, HJ;Wei, MF;Lee, HW;Liou, JM;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2016-02 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy
|
Chiang, NJ;Yeh, KH;Chiu, CF;Chen, JS;Yen, CC;Lee, KD;Lin, YL;Bai, LY;Chen, MH;Lin, JS;Yang, Y;Rau, KM;Hsiao, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2015-09 |
Expression of the Helicobater pylori CagA protein is closely associated with Helicobater pylori-dependence of early-stage high-grade gastric lymphoma
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Tsai, HJ;Tzeng, YS;Wu, MS;Hsu, PN;Cheng, AL |
| 國家衛生研究院 |
2015-06 |
Helicobacter pylori CagA translocation is closely associated with the expression of CagA-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Wu, MS;Liou, JM;Tsai, HJ;Tzeng, YS;Cheng, AL |
| 國家衛生研究院 |
2015-05 |
Heterogeneous cell origin of helicobater pylori-dependent high-grade gastric lymphomas
|
Kuo, SH;Chen, LT;Lin, CW;Yeh, KH;Tsai, HJ;Lee, HW;Wu, MS;Hsu, PN;Cheng, AL |
| 國家衛生研究院 |
2015-03 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, TC;Shiah, HS;Yang, CH;Yeh, KH;Cheng, AL;Shen, BN;Wang, YW;Yeh, CG;Chiang, NJ;Chang, JY;Chen, LT |
| 國家衛生研究院 |
2014-10 |
Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling
|
Kuo, SH;Yang, SH;Yeh, KH;Yeh, PY;Tien, YW;Lee, HW;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 國家衛生研究院 |
2014-06-20 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Hsu, C;Wu, MS;Tzeng, YS;Tsai, HJ;Wang, HP;Cheng, AL |
| 國家衛生研究院 |
2014-05 |
Association of helicobacter pylori CagA translocation with the expression of CagA-signaling transduction molecules in gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Chen, LT;Lin, CW;Hsu, PN;Wu, MS;Tsai, HJ;Tzeng, YS;Yeh, KH;Cheng, AL |
| 國家衛生研究院 |
2014-02 |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Kuo, SH;Tsai, HJ;Weng, WH;Li, CC;Yeh, KH;Chen, LT;Cheng, AL |
| 高雄醫學大學 |
2014 |
雙週給予將capecitabine及oxaliplatin合併作為一線化療藥物治療局部晚期或轉移胃癌的多中心臨床試驗第二期
|
趙毅;謝建勳;葉顯堂;蘇裕傑;吳誠中;陳仁熙;戴承正;白禮源;葉坤輝;蘇五州;李重賓; Y1, Chao;Hsieh, JS;Yeh, HT;Su, YC;Wu, CC;Chen, JS;Tai, CJ;Bai, LY;Yeh, KH;Su, WC;Li, CP. |
| 國家衛生研究院 |
2013-11 |
Management of gastric cancer in Asia: Resource-stratified guidelines
|
Shen, L;Shan, YS;Hu, HM;Price, TJ;Sirohi, B;Yeh, KH;Yang, YH;Sano, T;Yang, HK;Zhang, X;Park, SR;Fujii, M;Kang, YK;Chen, LT |
| 國家衛生研究院 |
2013-07 |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo, SH;Chen, LT;Lin, CW;Wu, MS;Hsu, PN;Tsai, HJ;Chu, CY;Tzeng, YS;Wang, HP;Yeh, KH;Cheng, AL |
| 國家衛生研究院 |
2013-06 |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply
|
Kuo, SH;Weng, WH;Yeh, KH;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2013-05 |
Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma
|
Lin, CCJ;Hsu, CH;Cheng, JC;Yen, CC;Shiah, HS;Huang, TC;Chen, WW;Wang, HP;Yeh, KH;Lee, JM;Cheng, AL |
| 國家衛生研究院 |
2013-05 |
Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-kappa B pathway activation through inhibition of BAFF
|
Kuo, SH;Chen, LT;Yeh, KH;Tsai, HJ;Lee, HW;Cheng, AL |
| 國家衛生研究院 |
2012-10 |
Front-line antibiotic therapy in early-stage H. Pylori-positive gastric Diffuse Large B-Cell Lymphomas with or without malt features
|
Chen, LT;Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Hsu, PN;Wang, HP;Cheng, AL |
| 國家衛生研究院 |
2012-05-24 |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Hsu, PN;Wang, HP;Chen, LT;Cheng, AL |
| 美和科技大學 |
2012-01 |
Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats.
|
Yeh KH;Sheu JJ;Lin YC;Sun CK;Chang LT;Kao YH;Yen CH;Shao PL;Tsai TH;Chen YL;Chua S;Leu S;Yip HK |
| 美和科技大學 |
2012 |
Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention
|
Tsai TH;Sung PH;Chang LT;Sun CK;Yeh KH;Chung SY;Chua S;Chen YL;Wu CJ;Chang HW;Ko SF;Yip HK |
| 國家衛生研究院 |
2011-12 |
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, SH;Cheng, AL;Lin, CW;Hsu, CH;Wu, MS;Yeh, KH;Tzeng, YS;Chen, LT |
| 國立成功大學 |
2011-12 |
MULTICHANNEL PLANAR MICROELECTRODEARRAY FOR SOMATIC MAPPING IN RATS
|
Shaw, FZ; Yang, TF; Huang, CC; Yeh, KH; Chang, TC; Leu, FJ |
| 國家衛生研究院 |
2011-11 |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma
|
Kuo, SH;Weng, WH;Chen, ZH;Hsu, PN;Wu, MS;Lin, CW;Jeng, HJ;Yeh, KH;Tsai, HJ;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, JS;Chao, Y;Hsieh, RK;Cheng, AL;Chen, PM;Chiou, TJ;Chao, TY;Yeh, KH;Chen, LT;Whang-Peng, J |
| 國家衛生研究院 |
2011-05 |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo, SH;Hsu, CH;Chen, LT;Lu, YS;Lin, CH;Yeh, PY;Jeng, HJ;Gao, M;Yeh, KH;Cheng, AL |
| 國立成功大學 |
2011-03 |
Differences in Filial Behavior in Multigeneration Families That Live Together
|
Liu, BS; Li, CY; Yeh, KH; Huang, HC |
| 高雄醫學大學 |
2011 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
|
趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. |
| 高雄醫學大學 |
2011 |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
|
郭頌鑫;陳立宗;鄭安理 ; Kuo SH;Weng WH;Chen ZH;Hsu PN;Wu MS;Lin CW;Jeng HJ;Yeh KH;Tsai HJ;Chen LT;Cheng AL. |
显示项目 1-50 / 108 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
|
